Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
69°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
111.75
+0.24 (+0.22%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
3
4
5
6
7
8
9
...
42
43
Next >
United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect
April 29, 2025
Biotechnology company United Therapeutics (NASDAQ:UTHR) will be reporting earnings tomorrow morning. Here’s what to look for.
Via
StockStory
Topics
Government
World Trade
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
April 28, 2025
Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
These S&P500 stocks are moving in today's session
April 28, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive...
Via
Chartmill
Earnings Scheduled For April 24, 2025
April 24, 2025
Via
Benzinga
P/E Ratio Insights for Gilead Sciences
April 23, 2025
Via
Benzinga
Exploring the top movers within the S&P500 index during today's session.
April 28, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
Incyte (INCY) Q1 Earnings Report Preview: What To Look For
April 28, 2025
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting results tomorrow morning. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
Government
World Trade
Regeneron (REGN) Reports Earnings Tomorrow: What To Expect
April 28, 2025
Biotech company Regeneron (NASDAQ:REGN) will be reporting earnings tomorrow morning. Here’s what you need to know.
Via
StockStory
Topics
World Trade
Dividend Investor in Mid-50s Making $23,800 A Month Shares Portfolio, Says He Started with $3.50/hour — 'Just 35 Years of Investing'
April 27, 2025
Via
Benzinga
Why Gilead Sciences Stock Slipped Today
April 25, 2025
Via
The Motley Fool
How Is The Market Feeling About Gilead Sciences?
April 25, 2025
Via
Benzinga
Wall Street Rally Pauses, Tesla Heads For Strongest Week In 6 Months: What's Driving Markets Friday?
April 25, 2025
Wall Street's three-day rally came to a pause on Friday, with major indices hovering near the flatline by midday in New York as caution returned amid mixed signals on U.S.-China trade relations.
Via
Benzinga
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
April 25, 2025
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.
Via
Chartmill
AbbVie Reports Upbeat Q1 Earnings, Raises 2025 Earnings Forecast: Retail’s Elated
April 25, 2025
The company’s immunology drugs, Skyrizi and Rinvoq, marked significant revenue growth, offsetting a 50.6% decrease in net revenue from its arthritis drug, Humira.
Via
Stocktwits
Topics
World Trade
Gilead Sciences Q1 Earnings Surpass Analyst Expectations, But Revenue Falls Short Of Estimates: Retail’s Optimistic
April 25, 2025
The company is eyeing FDA approval for its drug, lenacapavir, for HIV prevention by mid-June.
Via
Stocktwits
Topics
Government
Stocks
Skechers Posts Weak Revenue, Joins Intel, Gilead Sciences And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 25, 2025
Via
Benzinga
Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
April 25, 2025
Via
Benzinga
Alphabet, Intel And 3 Stocks To Watch Heading Into Friday
April 25, 2025
Via
Benzinga
Which S&P500 stocks are moving after the closing bell on Thursday?
April 24, 2025
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.
Via
Chartmill
Gilead (GILD) Q1 2025 Earnings Call Transcript
April 24, 2025
Via
The Motley Fool
Topics
Earnings
World Trade
Gilead Sciences Stock Slips After Mixed Q1 Results, Lowered FY25 EPS Guidance
April 24, 2025
Gilead Sciences releases its first-quarter results after Thursday's closing bell. Here's a look at the details from the report.
Via
Benzinga
Gilead Sciences (NASDAQ:GILD) Misses Q1 Revenue Estimates
April 24, 2025
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.67 billion. The company’s full-year revenue guidance...
Via
StockStory
Topics
Artificial Intelligence
Gilead Sciences' Bread-And-Butter Drug Missed Sales Views. And It's Not The Only One.
April 24, 2025
Biktarvy sales came in below forecasts. Will Gilead stock be able to shrug it off?
Via
Investor's Business Daily
Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher
April 24, 2025
BriaCell confirms complete resolution of lung metastasis at 4 months in Phase 1/2a trial using Bria-OTS immunotherapy in advanced breast cancer.
Via
Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
April 24, 2025
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade...
Via
Benzinga
Topics
Government
World Trade
Gilead Sciences's Options Frenzy: What You Need to Know
April 23, 2025
Via
Benzinga
Exploring Gilead Sciences's Earnings Expectations
April 23, 2025
Via
Benzinga
Gilead Sciences (GILD) To Report Earnings Tomorrow: Here Is What To Expect
April 23, 2025
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what you need to know.
Via
StockStory
Topics
Artificial Intelligence
Assessing Gilead Sciences: Insights From 15 Financial Analysts
April 22, 2025
Via
Benzinga
Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
April 21, 2025
Gilead's Trodelvy and Merck's Keytruda improved progression-free survival in PD-L1+ metastatic TNBC in a Phase 3 trial with no new safety concerns.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
42
43
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.